医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A post-hoc analysis of the Thai phase 3 efficacy trial RV 144

广告
第一作者: Robb,M.L.
作者单位: Data Management Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Biophics [1] EMMES Corporation, Rockville, MD, United States [2] US Military HIV Research Program, Division of Retrovirology, Walter Reed Army Institute of Research [3] Sanofi Pasteur, Swiftwater, PA, United States [4] Vaccine Trials Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand [5] National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD [6] Walter Reed Army Medical Center, Washington, DC, United States [7] Thai Components, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand [8] US Army Components, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, Henry [9] Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand [10] Global Solutions for Infectious Diseases, South San Francisco, CA, United States [11] Fred Hutchinson Cancer Research Center, Seattle, WA, United States [12]
发布时间 2013-11-20
提交
  • 浏览0
The Lancet infectious diseases

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷